GONUTS has been updated to MW1.31 Most things seem to be working but be sure to report problems.

Have any questions? Please email us at ecoliwiki@gmail.com

TableEdit

Jump to: navigation, search

PMID:20032056

You don't have sufficient rights on this wiki to edit tables. Perhaps you need to log in. Changes you make in the Table editor will not be saved back to the wiki

See Help for Help on this wiki. See the documentation for how to use the table editor

Citation

Liang, L, Guo, WH, Esquiliano, DR, Asai, M, Rodriguez, S, Giraud, J, Kushner, JA, White, MF and Lopez, MF (2010) Insulin-like growth factor 2 and the insulin receptor, but not insulin, regulate fetal hepatic glycogen synthesis. Endocrinology 151:741-7

Abstract

Whether insulin or IGFs regulate glycogen synthesis in the fetal liver remains to be determined. In this study, we used several knockout mouse strains, including those lacking Pdx-1 (pancreatic duodenal homeobox-1), Insr (insulin receptor), and Igf2 (IGF-II) to determine the role of these genes in the regulation of fetal hepatic glycogen synthesis. Our data show that insulin deficiency does not alter hepatic glycogen stores, whereas Insr and Igf2 deficiency do. We found that both insulin receptor isoforms (IR-A and IR-B) are present in the fetal liver, and their expression is gestationally regulated. IR-B is highly expressed in the fetal liver; nonetheless, the percentage of hepatic IR-A isoform, which binds Igf2, was significantly higher in the fetus than the adult. In vitro experiments demonstrate that Igf2 increases phosphorylation of hepatic Insr, insulin receptor substrate-2, and Akt proteins and also the activity of glycogen synthase. Igf2 ultimately increased glycogen synthesis in fetal hepatocytes. This increase could be blocked by the phosphoinositide 3-kinase inhibitor LY294008. Taken together, we propose Igf2 as a major regulator of fetal hepatic glycogen metabolism, the insulin receptor as its target receptor, and phosphoinositide 3-kinase as the signaling pathway leading to glycogen formation in the fetal liver.

Links

PubMed PMC2817628 Online version:10.1210/en.2009-0705

Keywords

Animals; Cells, Cultured; Crosses, Genetic; DNA Primers; Female; Fetus/drug effects; Fetus/physiology; Glycogen Synthase/metabolism; Hepatocytes/cytology; Hepatocytes/enzymology; Hepatocytes/physiology; Heterozygote; Homeostasis; Insulin/deficiency; Insulin/genetics; Insulin/physiology; Insulin-Like Growth Factor II/deficiency; Insulin-Like Growth Factor II/genetics; Insulin-Like Growth Factor II/physiology; Liver Glycogen/blood; Male; Mice; Mice, Knockout; RNA, Messenger/genetics; Receptor, Insulin/deficiency; Receptor, Insulin/genetics; Receptor, Insulin/physiology

public



Cancel